C12Y 301/25
Site-specific endodeoxyribonucleases specific for altered bases
Official title: Site-specific endodeoxyribonucleases specific for altered bases (3.1.25)
C12Y301/25 (Site-specific endodeoxyribonucleases specific for altered bases) appears on 7 US grants and 13 published applications in this corpus.
Search patents in C12Y- Granted patents
- 7
- Published applications
- 13
- Assignees
- 8
- Inventors
- 37
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 2 | 2 |
| 2023 | 1 | 3 |
| 2024 | 2 | 2 |
| 2025 | 1 | 2 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations20 Jan 2026US 12,529,100 B2Roche Sequencing Solutions, Inc.
- Compositions comprising a CRISPR nuclease and uses thereof1 Jul 2025US 12,344,870 B2Arbor Biotechnologies, Inc.
- Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene11 Jun 2024US 12,006,522 B2Precision BioSciences, Inc.
- Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene28 May 2024US 11,993,793 B2Precision BioSciences, Inc.
- Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene12 Sep 2023US 11,753,630 B2Precision BioSciences, Inc.
- Muscle-specific expression cassettes19 Mar 2026US 2026/0078408 A1Precision BioSciences, Inc.
- Compositions comprising a crispr nuclease and uses thereof18 Sep 2025US 2025/0290053 A1Arbor Biotechnologies, Inc.
- Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene30 Jan 2025US 2025/0034536 A1Precision BioSciences, Inc.
- Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene18 Jan 2024US 2024/0018495 A1Precision BioSciences, Inc.
- Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene4 Jan 2024US 2024/0002823 A1Precision BioSciences, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.